Show simple item record

dc.contributor.advisorHutt, Peter Bartonen_US
dc.contributor.authorPirina, Jean C.en_US
dc.date.accessioned2012-06-07T20:09:40Z
dc.date.issued2004en_US
dc.identifier.citationThe Regulation of Tea and Its Health-Related Claims in the Wake of Developing Scientific Evidence: Food, Drug, or Dietary Supplement? (2004 Third Year Paper)en
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:8852111
dc.description.abstractThis paper examines the place of tea in cultural and regulatory American society. Scientific evidence now abounds about the potential health benefits of tea, and this has put pressure on regulators at the Food and Drug Administration to insure that consumers are well protected. The health claims of tea must be evaluated and screened to avoid consumer fraud. To accomplish this, regulators must first determine what category tea falls under for purposes of the Food, Drug and Cosmetic Act. Unfortunately, this is no easy task given the wide array of potential uses for tea. Therefore, in a modern society where the Internet supplies much of consumers’ information, lawmakers and regulators will have to adopt a regulatory scheme that is equipped to handle a diverse and emerging product.en
dc.language.isoen_USen
dash.licenseLAAen_US
dc.subjectFood and Drug Lawen
dc.subjectteaen
dc.subjecthealth claimsen
dc.titleThe Regulation of Tea and Its Health-Related Claims in the Wake of Developing Scientific Evidence: Food, Drug, or Dietary Supplement?en
dc.typePaper (for course/seminar/workshop)en_US
dc.date.available2012-06-07T20:09:40Z
dash.authorsorderedfalse


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record